The protein synthesis inhibitors, oxazolidinones and chloramphenicol, cause extensive translational inaccuracy in vivo.
暂无分享,去创建一个
[1] B. Stockman,et al. 1H Nuclear Magnetic Resonance Study of Oxazolidinone Binding to Bacterial Ribosomes , 2002, Antimicrobial Agents and Chemotherapy.
[2] F. Schluenzen,et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.
[3] H. Noller,et al. Analysis of mutations at residues A2451 and G2447 of 23S rRNA in the peptidyltransferase active site of the 50S ribosomal subunit , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. Peterson,et al. Resistance to Linezolid: Characterization of Mutations in rRNA and Comparison of Their Occurrences in Vancomycin-Resistant Enterococci , 2001, Antimicrobial Agents and Chemotherapy.
[5] V. Ramakrishnan,et al. Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit , 2001, Science.
[6] C. Squires,et al. Mutagenesis of the peptidyltransferase center of 23S rRNA: the invariant U2449 is dispensable. , 2001, Nucleic acids research.
[7] S. Douthwaite,et al. Oxazolidinone Resistance Mutations in 23S rRNA ofEscherichia coli Reveal the Central Region of Domain V as the Primary Site of Drug Action , 2000, Journal of bacteriology.
[8] T. Steitz,et al. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. , 2000, Science.
[9] A. Mankin,et al. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. , 1999, Journal of molecular biology.
[10] M. Rodnina,et al. Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors. , 1999, RNA.
[11] C. Squires,et al. An Escherichia coli strain with all chromosomal rRNA operons inactivated: complete exchange of rRNA genes between bacteria. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Aoki,et al. The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria , 1998, Antimicrobial Agents and Chemotherapy.
[13] M. Ruiz-Echevarría,et al. Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents , 1998, Trends in Biotechnology.
[14] K. Schimz,et al. On the target of a novel class of antibiotics, oxazolidinones, active against multidrug‐resistant Gram‐positive bacteria , 1998, FEBS letters.
[15] K. Marotti,et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions , 1997, Antimicrobial agents and chemotherapy.
[16] K. Marotti,et al. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin , 1997, Antimicrobial agents and chemotherapy.
[17] K. Lieberman,et al. Genetic probes of ribosomal RNA function. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[18] J. F. Atkins,et al. rRNA-mRNA base pairing stimulates a programmed -1 ribosomal frameshift , 1994, Journal of bacteriology.
[19] J. F. Atkins,et al. Deficiency of 1-methylguanosine in tRNA from Salmonella typhimurium induces frameshifting by quadruplet translocation. , 1993, Journal of molecular biology.
[20] M. O'Connor,et al. A ribosomal ambiguity mutation in the 530 loop of E. coli 16S rRNA. , 1992, Nucleic acids research.
[21] S. Douthwaite. Functional interactions within 23S rRNA involving the peptidyltransferase center , 1992, Journal of bacteriology.
[22] W. Craigen,et al. Recent advances in peptide chain termination , 1990, Molecular microbiology.
[23] P. Feldman,et al. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis , 1988, Antimicrobial Agents and Chemotherapy.
[24] M. A. Wuonola,et al. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721 , 1987, Antimicrobial Agents and Chemotherapy.
[25] H. Noller,et al. Gene organization and primary structure of a ribosomal RNA operon from Escherichia coli. , 1981, Journal of molecular biology.
[26] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[27] B. D. Davis,et al. Phenotypic Suppression in Escherichia coli by Chloramphenicol and Other Reversible Inhibitors of the Ribosome , 1969, Journal of bacteriology.
[28] C. Sigmund,et al. Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. , 1988, Methods in enzymology.
[29] R. Weiss,et al. Slippery runs, shifty stops, backward steps, and forward hops: -2, -1, +1, +2, +5, and +6 ribosomal frameshifting. , 1987, Cold Spring Harbor symposia on quantitative biology.
[30] Jeffrey H. Miller. Experiments in molecular genetics , 1972 .
[31] Ernest Frederick Gale,et al. The Molecular basis of antibiotic action , 1972 .